Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icodextrin versus glucose 2.27% for plasma and extracellular volume in peritoneal dialysis
NL-OMON30588Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of icodextrin and glucose in kidney failure and Renal Insufficiency (RI) (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Plasma volume, Extracellular volume and 1 more. Planned start Jan 2007; status: not yet recruiting.
02
Drugs
icodextringlucose
03
Conditions
kidney failureRenal Insufficiency (RI)
Beyond the preview
Go deeper on NL-OMON30588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30588.